James Mitchell
Corporate Officer/Principal presso PAVMED INC.
Profilo
James Mitchell has founded Oncodisc, Inc. in 2018, where he currently holds the title of Chief Executive Officer.
He is also currently employed at PAVmed, Inc. as Vice President-Digital Health since 2021.
Posizioni attive di James Mitchell
| Società | Posizione | Inizio |
|---|---|---|
| PAVMED INC. | Corporate Officer/Principal | 01/06/2021 |
Oncodisc, Inc.
 Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Amministratore Delegato | 01/01/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PAVMED INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Oncodisc, Inc.
Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Technology Services |
- Borsa valori
- Insiders
- James Mitchell
